Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-10-21FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Metoprolol Tartrate from Mylan Pharmaceuticals Inc., authorizing a generic version to be mar…
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Assessment of Myocardial Viability Using Multidetector Computed Tomography [NA]
The trial evaluated myocardial viability assessment with multidetector CT in patients with myocardial infarction, and its status is now comp…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Coronary Thromboaspiration and Infarct Size [NA]
A clinical trial evaluating coronary thromboaspiration and infarct size in ischemic heart disease and acute myocardial infarction has been t…
-
CLINICAL_TRIALS trial_result · 2008-10-07Clinical Trial Update: Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI [NA]
This completed clinical trial evaluated whether low-dose dobutamine with Tc-99m MIBI gated SPECT can predict left ventricular remodeling aft…
-
CLINICAL_TRIALS trial_result · 2008-10-06Clinical Trial Update: Long Term Clinical Efficacy of Thrombectomy Devices in Acute ST Elevation Myocardial Infarction [Phase 4]
This update reports long-term clinical efficacy data from a Phase 4 trial evaluating thrombectomy devices in patients with acute myocardial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-02Clinical Trial Update: Alcohol, Inflammation and Atherosclerosis [NA]
Clinical trial NCT00764426, sponsored by the European Research Advisory Board, studied the relationship between alcohol, inflammation, and a…
-
FDA approval · 2008-09-30FDA Approved: CARVEDILOL — Supplemental Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved a supplemental application for carvedilol from Unichem Pharmaceuticals (USA), Inc., expanding labeling for this product.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Beyond 12 Hours Reperfusion AlternatiVe Evaluation Trial [Phase 4]
Phase 4 trial evaluating beyond-12-hours reperfusion strategies for myocardial infarction has completed. No trial results or drug specifics …
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Drug Eluting Stent (DES) in Primary Angioplasty [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a Drug Eluting Stent used in primary angioplasty for acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study [NA]
A completed prospective double-blind randomized placebo-controlled trial evaluated the effect of granulocyte colony-stimulating factor (G-CS…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction [Phase 1, Phase 2]
A completed Phase I–II safety study evaluated whether filgrastim (Neupogen) can improve left ventricular function after acute myocardial inf…
-
CLINICAL_TRIALS trial_result · 2008-09-16Clinical Trial Update: SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes [Phase 3]
Phase 3 SYNERGY trial comparing enoxaparin to unfractionated heparin in patients with acute coronary syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-16Clinical Trial Update: Strain-Encoded Magnetic Resonance Imaging in Acute Myocardial Infarction
Completed clinical trial evaluating strain-encoded MRI in patients with Acute Myocardial Infarction.
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction [Phase 3]
Phase 3 trial evaluating whether omega-3 fatty acids reduce sudden cardiac death after myocardial infarction has completed. The update notes…
-
CLINICAL_TRIALS trial_result · 2008-09-10Clinical Trial Update: Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle [Phase 1]
This clinical trial update reports the completion of a Phase 1 safety study evaluating bone marrow–derived cells for treating damaged heart …
-
CLINICAL_TRIALS research · 2008-09-05Clinical Trial Update: The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial) [NA]
This entry provides an update on the VIAMI-Trial evaluating viability-guided angioplasty after acute myocardial infarction; the current tria…
-
CLINICAL_TRIALS trial_result · 2008-09-04Clinical Trial Update: Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) [Phase 3]
A Phase 3 clinical trial update assessing the safety and efficacy of eptifibatide during primary percutaneous coronary intervention in patie…
-
FDA approval · 2008-08-29FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under the ANDA.
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: Study of Rehabilitation Therapy on Patients After Acute Myocardial Infarction [NA]
This document provides an update on a clinical study evaluating rehabilitation therapy for patients after an acute myocardial infarction.
-
FDA approval · 2008-08-22FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. to market a generi…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Pharmacogenetics and Cardiovascular Events
This update reports the completion of an NHLBI-sponsored trial examining pharmacogenetic factors and cardiovascular events across several ca…
-
CLINICAL_TRIALS trial_result · 2008-08-20Clinical Trial Update: Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI) [NA]
Clinical trial NCT00497419 investigating reperfusion time in STEMI has completed; the study status is finished.
-
CLINICAL_TRIALS research · 2008-08-19Clinical Trial Update: Combined CABG and Stem-Cell Transplantation for Heart Failure [Phase 2]
Phase 2 clinical trial evaluating combined coronary artery bypass grafting and stem-cell transplantation for heart failure is in progress; c…
-
FDA label_change · 2008-08-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction [Phase 4]
Phase 4 trial evaluating whether giving streptokinase intracoronarily after primary PCI improves microvascular perfusion and reduces late in…